Physician profile
John Michael Kleback
NPI 1184629255
$608.49
in general payments reported to CMS, 2019-2025
11 companies · $215 in 2025
The $215 reported for 2025 was more than what 76% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.99 · 2021: $60.55 · 2022: $69.52 · 2023: $40.84 · 2024: $207 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $462.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $144.90 | 2024-2025 | Doc Band |
| Merck Sharp & Dohme LLC | $106.41 | 2024-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Sanofi Pasteur INC. | $66.88 | 2023-2025 | |
| Pfizer INC. | $66.53 | 2021-2024 | |
| Glaxosmithkline, LLC. | $58.08 | 2022-2024 | Bexsero |
| Kaleo, INC. | $46.04 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $30.43 | 2025 | |
| Corium, LLC | $24.22 | 2022 | |
| Alk-Abello, INC | $23.74 | 2025 | Neffy |
| Collegium Pharmaceutical, INC. | $21.79 | 2025 | Jornay Pm |
| Seqirus USA INC | $19.47 | 2025 | Flucelvax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kleback listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.